Delivery Order SPE2DB24D2212-SPE2DB25FHQVA
- Not listed
- The Defense Logistics Agency awarded a $31,982.02 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 5, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $35,074.07 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract is non-set-aside and competitively awarded, with an ultimate completion date of August 13, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $57,995.91 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units), with an ultimate completion date of August 28, 2025. This contract employs firm fixed pricing and carries no set-aside designation, reflecting competitive procurement through open competition. The order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $59,631.98 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order...
- The Defense Logistics Agency awarded a $33,897.39 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $24,229.80 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 tablets per unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The contract specifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $22,405.18 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $23,458.54 delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a $15,540.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract represents a non-competitive, non-set-aside award and carries an ultimate completion date of June 25, 2025. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $53,908.10 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQVADelivery Order
The Defense Logistics Agency awarded a $14,017.54 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Biktarvy 50-200-25 mg tablets in units of 30 tablets. This is a firm fixed price contract with an ultimate completion date of September 17, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. The company's relationship with DLA encompasses a comprehensive range of therapeutic categories including specialty medications, vaccines, and medical devices. This particular delivery order for Biktarvy, an antiretroviral medication, reflects the company's ongoing role in supplying essential pharmaceutical commodities to support military healthcare programs globally. The competitively awarded contract demonstrates AmerisourceBergen Drug Corp's capability to meet federal procurement requirements and support the Defense Health Agency and other government healthcare systems through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 9/16/25 |